Omics of cancer

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 9, 2012, Pages 4229-4233

  Bhati, Aniruddha ^a   Garg, H ^a   Gupta, A ^a   Chhabra, H ^a   Kumari, A ^a   Patel, T ^a  

^a VIT UNIVERSITY   (India)

Author keywords

Epigenomics; Genomics; Proteomics; Transcriptomics

Indexed keywords

EID: 84874003801     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.9.4229     Document Type: Short Survey

References (41)

1. Bardelli A, Parsons DW, Silliman N, et al (2003). Mutational analysis of the tyrosine kinome in colorectal cancers. Science, 300, 949.
2. Bentley DR (2006). Whole-genome re-sequencing. Curr Opin Genet Dev, 16, 545-52.
3. Benvenuti S, Arena S, Bardelli A (2005). Identification of cancer genes by mutational profiling of tumor genomes. FEBS Lett, 579, 1884-90.
4. Bernstein BE, Meissner A, Lander ES (2007). The mammalian epigenome. Cell, 2, 669-81.
5. Bird A (2007). Perceptions of epigenetics. Nature, 447, 396-8.
6. Ding L, Getz G, Wheeler DA, et al (2008). Somatic mutations affect key pathways in lung adenocarcinoma. Nature, 455, 1069-75.
7. Estécio MR, Issa JP (2011). Dissecting DNA hypermethylation in cancer. FEBS Letters, 585, 2078-86.
8. Feber A (2010). Global profiling of methylation in the cancer genome. Cancer Genet Cytogenet, 203, 44-65.
9. Fiers W, Contreras R, Duerinck F (1976). Complete nucleotide- sequence of bacteriophage MS2-RNA - primary and secondary structure of replicase gene. Nature, 260, 500-7.
10. Hanash SM, Pitted SJ, Faca VM (2008). Mining the plasma proteome for cancer biomarkers. Nature, 452, 571-9.
11. Holliday R (1990). Mechanisms for the control of gene activity during development. BiolRev Cambr Philos Soc, 65,431-71.
12. Hoque MO, Kim MS, Ostrow KL, et al (2008). Genome-wide promoter analysis uncovers portions of the cancer methylome. Cancer Res, 68, 2661-70. http://www.ncbi.nlm.nih.gov/genome.
13. Hudson TJ, Anderson W, Artez A, et al (2010). International Cancer Genome Consortium. International network of cancer genome projects. Nature, 464, 993-8.
14. Jones S, Hruban RH, Kamiyama M, et al (2009). Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science, 324, 217.
15. La Deana WH, Valerie R, Philip G, et al (2009). Massively parallel sequencing of the polyadenylated transcriptome of C elegans. Genome Res, 19, 657-66.
16. Lander ES, Linton LM, Birren B, et al (2001). Initial sequencing and analysis of the human genome. Nature, 409, 860-921.
17. Lay JO, Borgmann S, Liyanage R, Wilkins C L (2006). Problems with the "omics". Trends in Analytical Chemistry, 25, 11.
18. Lederberg J, McCray AT (2001). 'Ome Sweet 'Omics-A genealogical treasury of words. The Scientist, 15, 8.
19. Li X, Shen S, Wu M, et al (2011). Transcriptomic regulation and molecular mechanism of polygenic tumor at different stages. ZhongNanDaXueXueBao YiXueBan, 36, 585-91.
20. Moore LE, Pfeiffer RM, Zhang Z, et al (2012). Proteomic biomarkers in combination with CA125 for detection of epithelial ovarian cancer using pre-diagnostic serum samples from the prostate lung colon and ovary (PLCO) cancer screening trial. Cancer, 118, 91-100.
21. Morel NM, Holland JM, van der Greef J, et al (2004). Primer on medical genomics part XIV: Introduction to systems biology-A new approach to understanding disease and treatment. Mayo Clin Proc, 79, 651-8.
22. Murray S, Linardou H (2004). Proteomics and Cancer. STEP KAINIKH2 OrKOAOriAS, 3, 49-56.
23. Ng PC, Levy S, Huang J, et al (2008). Genetic variation in an individual human exome. PLoS Genetics, 4, 1000160.
24. Olsvik O, Wahlberg J, Petterson B, et al (1993).- Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae Ol strains. J Clin Microbiol, 31, 22-5.
25. Pettersson E, Lundeberg J, Ahmadian A (2009). Generations of sequencing technologies. Genomics, 93, 105-11.
26. Raphael BJ, Volik S, Collins C, Pevzner PA (2003). Reconstructing tumor genome architectures. Bioinformatics, 19, 162-71.
27. Sanger F, Air GM, Barrell BG, et al (1977). Nucleotide sequence of bacteriophage phi X174 DNA. Nature, 265, 687-95.
28. Sarah BN, Emily HT, Peggy DR, et al (2009). Targeted capture and massively parallel sequencing of 12 human exomes. Nature, 461, 272-76.
29. Schuster SC (2008). Next-generation sequencing transforms today's biology. Nat Methods, 5, 16-8.
30. Shah SP, Morin RD, Khattra J, et al (2009). Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature, 461, 809-13.
31. Sjöblom T, Jones S, Wood LD, et al (2006). The consensus coding sequences of human breast and colorectal cancers. Science, 314, 268-74.
32. Stadler ZK, Vijai J, Thorn P, et al (2010). Genome-wide association studies of cancer predisposition. Hematol Oncol Clin North Am, 24, 973-96.
33. Stephens PJ, McBride DJ, Lin ML, et al (2009). Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature, 462, 1005-10.
34. Taguchi A, Politi K, Pitted, et al (2011). Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell, 20, 289-99.
35. Tripathi AK, Koringa PG, Jakhesara SJ, et al (2012). A preliminary sketch of horn cancer transcriptome in Indian zebu cattle. Gene, 1, 124-31.
36. Varela I, Tarpey P, Raine K, et al (2011). Exome sequencing identifies frequentmutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature, 469, 539-42.
37. Venter CJ, Adams DM, Myers WE, et al (2001). The sequence of the human genome. Science, 291, 1304-51.
38. Volik S, Zhao S, Chin K, et al (2003). End-sequence profiling: Sequence-based analysis of aberrant genomes. Proc Natl AcadSci, 100, 7696-701.
39. Wei X, Walia V, Lin JC, et al (2011). Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nature Genetics, 43, 442-6.
40. Weir BA, Michele S. Woo MS, Getz G, et al (2007). Characterizing the cancer genome in lung adenocarcinoma. Nature, 450, 893-8.
41. Wilkins MR, Appel R, Jennifer EVE, et al (1994). Guidelines for next 10 years of proteins. Proteomics, 6, 4-8.